Data-Driven Insights

What Happens When Doctors Start Asking Who Makes Your Generic?

March 25, 2014   |   Josh Halpern

Who makes your generic?

I recently read an article by Toni Clarke and Bill Berkrot, “Unease grows among US doctors over Indian drug quality.” The piece raised some interesting points around the quality of imported drugs and the fact that doctors are starting to question the origin of the drugs they are prescribing to their patients.

Recently, the FDA banned the importation of products from certain pharmaceutical manufacturers due to quality control problems, including data manipulation and sanitation. According to the article, “Some US doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration.”

With all of that taken into consideration, we need to step back and also realize that 85% of medicines prescribed in the US are generics, and India supplies 40% of those generic medicines, including over-the-counter drugs.

With a growing distrust from doctors in regards to drugs manufactured in India, and certainly other countries with similar quality control for medications, one must also consider the implications for patients. What if patients start raising the same concerns doctors are about their specific generic manufacturer with the pharmacist? Does this create an opportunity for secondary generic suppliers to gain business in the chain? If so, how will generic suppliers need to use their channel data in order to sense and respond to what could be rapidly emerging business opportunities?

In the comments, I’d love to hear your opinions regarding whether or not this trend will create an opportunity for manufacturers of novel brands struggling in heavily genericized therapeutic categories to gain renewed traction? If so, what role will the pharmacy (and by extension, channel data) play

Tags: , , ,

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand